VasThera

Private

SeoulHealthcare & Life Scienceshttps://www.vasthera.com/

Last Round

Series B

Mar 2, 2022

Total Funding Raised

$19.87M

Company Overview

VasThera is a pharmaceutical company that develops synthetic therapeutic solutions for vascular hyperplasia and other cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryvascular diseasepulmonary arterial hypertensionPAHsmall-molecule drugsperoxiredoxinPRXredox signalingbiotech startupdrug pipelinetherapeutic solutionsbiopharmaclinical-stage biotechdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VasThera Comps

Public and private peers based on sector, stage, and business model.

VasThera comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VasThera Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 2, 2022
Series A	Nov 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

SANGWON KANG

CEO

Executive Team

VasThera Investors

Notable investors and investment history

VasThera investors
Investor	Rounds
ID Ventures	Series A, Series B
Shinhan Venture Investment	Series B
UTC Investment	Series B
Medici Investment	Series B
Partners Investment	Series B

View all Investors

VasThera Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VasThera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VasThera's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range5

Year Founded2018

Last FundingMar 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.